GENEVA, Aug. 21 -- BIOCRYST PHARMACEUTICALS, INC. filed a patent application (US2026/015231) for “INHIBITORS OF COMPLEMENT PROTEIN C5”. With publication no. WO/2026/174171, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/404
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....